{"entity":{"type":"insider","cik":"0001335659","url":"/insider/0001335659","json_url":"/insider/0001335659.json","name":"Krieg Arthur M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":13,"first":"2006-10-16","last":"2021-06-21","span_basis":"filed_date"},"name_variants":[{"name":"Krieg Arthur M","source":"filing","n_filings":13,"first_seen":"2006-10-16","last_seen":"2021-06-21"}],"transactions":[{"id":4162948,"accession":"0000899243-21-024984","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-024984","line_url":"/filing/0000899243-21-024984#line-1","is_derivative":false,"issuer_cik":"0001335659","issuer_name":"Checkmate Pharmaceuticals, Inc.","issuer_ticker":"CMPI","issuer_name_source":null,"issuer_url":"/issuer/0001335659","owner_cik":"0001335659","owner_name":"Krieg Arthur M","owner_display_name":"Krieg Arthur M","owner_url":"/insider/0001335659","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7224.0,"shares_display":"7,224","price_per_share":6.04,"price_display":"6.04","price_state":"stated","total_value":43632.96,"total_display":"43,632.96","total_whole":"43,633","shares_owned_after":815734.0,"shares_owned_after_display":"815,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-18","filed_date":"2021-06-21","scope":"insider"},{"id":5237320,"accession":"0000899243-21-024427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-024427","line_url":"/filing/0000899243-21-024427#line-1","is_derivative":false,"issuer_cik":"0001335659","issuer_name":"Checkmate Pharmaceuticals, Inc.","issuer_ticker":"CMPI","issuer_name_source":null,"issuer_url":"/issuer/0001335659","owner_cik":"0001335659","owner_name":"Krieg Arthur M","owner_display_name":"Krieg Arthur M","owner_url":"/insider/0001335659","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3578.0,"shares_display":"3,578","price_per_share":6.18,"price_display":"6.18","price_state":"stated","total_value":22112.04,"total_display":"22,112.04","total_whole":"22,112","shares_owned_after":808510.0,"shares_owned_after_display":"808,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-16","filed_date":"2021-06-17","scope":"insider"},{"id":4084571,"accession":"0000899243-21-019922","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-019922","line_url":"/filing/0000899243-21-019922#line-1","is_derivative":false,"issuer_cik":"0001335659","issuer_name":"Checkmate Pharmaceuticals, Inc.","issuer_ticker":"CMPI","issuer_name_source":null,"issuer_url":"/issuer/0001335659","owner_cik":"0001335659","owner_name":"Krieg Arthur M","owner_display_name":"Krieg Arthur M","owner_url":"/insider/0001335659","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25001.0,"shares_display":"25,001","price_per_share":6.97,"price_display":"6.97","price_state":"stated","total_value":174256.97,"total_display":"174,256.97","total_whole":"174,257","shares_owned_after":804932.0,"shares_owned_after_display":"804,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-18","filed_date":"2021-05-19","scope":"insider"},{"id":5030255,"accession":"0000899243-21-014278","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-014278","line_url":"/filing/0000899243-21-014278","is_derivative":false,"issuer_cik":"0001335659","issuer_name":"Checkmate Pharmaceuticals, Inc.","issuer_ticker":"CMPI","issuer_name_source":null,"issuer_url":"/issuer/0001335659","owner_cik":"0001335659","owner_name":"Krieg Arthur M","owner_display_name":"Krieg Arthur M","owner_url":"/insider/0001335659","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33220.0,"shares_display":"33,220","price_per_share":11.158119205298012,"price_display":"11.16","price_state":"stated","total_value":370672.72,"total_display":"370,672.72","total_whole":"370,673","shares_owned_after":764179.0,"shares_owned_after_display":"764,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-29","filed_date":"2021-03-31","scope":"insider","n_lines":2},{"id":5318399,"accession":"0000899243-21-013801","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-013801","line_url":"/filing/0000899243-21-013801#line-2","is_derivative":false,"issuer_cik":"0001335659","issuer_name":"Checkmate Pharmaceuticals, Inc.","issuer_ticker":"CMPI","issuer_name_source":null,"issuer_url":"/issuer/0001335659","owner_cik":"0001335659","owner_name":"Krieg Arthur M","owner_display_name":"Krieg Arthur M","owner_url":"/insider/0001335659","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3484.0,"shares_display":"3,484","price_per_share":12.15,"price_display":"12.15","price_state":"stated","total_value":42330.6,"total_display":"42,330.60","total_whole":"42,331","shares_owned_after":746711.0,"shares_owned_after_display":"746,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-26","filed_date":"2021-03-29","scope":"insider"},{"id":5318394,"accession":"0000899243-21-013801","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-013801","line_url":"/filing/0000899243-21-013801#line-1","is_derivative":false,"issuer_cik":"0001335659","issuer_name":"Checkmate Pharmaceuticals, Inc.","issuer_ticker":"CMPI","issuer_name_source":null,"issuer_url":"/issuer/0001335659","owner_cik":"0001335659","owner_name":"Krieg Arthur M","owner_display_name":"Krieg Arthur M","owner_url":"/insider/0001335659","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10036.0,"shares_display":"10,036","price_per_share":12.35,"price_display":"12.35","price_state":"stated","total_value":123944.6,"total_display":"123,944.60","total_whole":"123,945","shares_owned_after":743227.0,"shares_owned_after_display":"743,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-25","filed_date":"2021-03-29","scope":"insider"},{"id":4811296,"accession":"0000899243-21-003613","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-003613","line_url":"/filing/0000899243-21-003613#line-1","is_derivative":false,"issuer_cik":"0001335659","issuer_name":"Checkmate Pharmaceuticals, Inc.","issuer_ticker":"CMPI","issuer_name_source":null,"issuer_url":"/issuer/0001335659","owner_cik":"0001335659","owner_name":"Krieg Arthur M","owner_display_name":"Krieg Arthur M","owner_url":"/insider/0001335659","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1701.0,"shares_display":"1,701","price_per_share":13.05,"price_display":"13.05","price_state":"stated","total_value":22198.05,"total_display":"22,198.05","total_whole":"22,198","shares_owned_after":733191.0,"shares_owned_after_display":"733,191","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-27","filed_date":"2021-01-28","scope":"insider"},{"id":4707421,"accession":"0000899243-21-002720","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-002720","line_url":"/filing/0000899243-21-002720#line-1","is_derivative":false,"issuer_cik":"0001335659","issuer_name":"Checkmate Pharmaceuticals, Inc.","issuer_ticker":"CMPI","issuer_name_source":null,"issuer_url":"/issuer/0001335659","owner_cik":"0001335659","owner_name":"Krieg Arthur M","owner_display_name":"Krieg Arthur M","owner_url":"/insider/0001335659","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":13.09,"price_display":"13.09","price_state":"stated","total_value":6545.0,"total_display":"6,545.00","total_whole":"6,545","shares_owned_after":731490.0,"shares_owned_after_display":"731,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-21","scope":"insider"},{"id":2601914,"accession":"0000899243-20-035557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-035557","line_url":"/filing/0000899243-20-035557#line-1","is_derivative":false,"issuer_cik":"0001335659","issuer_name":"Checkmate Pharmaceuticals, Inc.","issuer_ticker":"CMPI","issuer_name_source":null,"issuer_url":"/issuer/0001335659","owner_cik":"0001335659","owner_name":"Krieg Arthur M","owner_display_name":"Krieg Arthur M","owner_url":"/insider/0001335659","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":443.0,"shares_display":"443","price_per_share":14.16,"price_display":"14.16","price_state":"stated","total_value":6272.88,"total_display":"6,272.88","total_whole":"6,273","shares_owned_after":730990.0,"shares_owned_after_display":"730,990","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-29","filed_date":"2020-12-31","scope":"insider"},{"id":2067077,"accession":"0000899243-20-034982","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-034982","line_url":"/filing/0000899243-20-034982#line-1","is_derivative":false,"issuer_cik":"0001335659","issuer_name":"Checkmate Pharmaceuticals, Inc.","issuer_ticker":"CMPI","issuer_name_source":null,"issuer_url":"/issuer/0001335659","owner_cik":"0001335659","owner_name":"Krieg Arthur M","owner_display_name":"Krieg Arthur M","owner_url":"/insider/0001335659","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5103.0,"shares_display":"5,103","price_per_share":14.64,"price_display":"14.64","price_state":"stated","total_value":74707.92,"total_display":"74,707.92","total_whole":"74,708","shares_owned_after":730547.0,"shares_owned_after_display":"730,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-22","filed_date":"2020-12-23","scope":"insider"},{"id":2288572,"accession":"0000899243-20-034308","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-034308","line_url":"/filing/0000899243-20-034308#line-2","is_derivative":false,"issuer_cik":"0001335659","issuer_name":"Checkmate Pharmaceuticals, Inc.","issuer_ticker":"CMPI","issuer_name_source":null,"issuer_url":"/issuer/0001335659","owner_cik":"0001335659","owner_name":"Krieg Arthur M","owner_display_name":"Krieg Arthur M","owner_url":"/insider/0001335659","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4805.0,"shares_display":"4,805","price_per_share":14.62,"price_display":"14.62","price_state":"stated","total_value":70249.1,"total_display":"70,249.10","total_whole":"70,249","shares_owned_after":725444.0,"shares_owned_after_display":"725,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2020-12-17","scope":"insider"},{"id":2288567,"accession":"0000899243-20-034308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-034308","line_url":"/filing/0000899243-20-034308#line-1","is_derivative":false,"issuer_cik":"0001335659","issuer_name":"Checkmate Pharmaceuticals, Inc.","issuer_ticker":"CMPI","issuer_name_source":null,"issuer_url":"/issuer/0001335659","owner_cik":"0001335659","owner_name":"Krieg Arthur M","owner_display_name":"Krieg Arthur M","owner_url":"/insider/0001335659","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42.0,"shares_display":"42","price_per_share":14.49,"price_display":"14.49","price_state":"stated","total_value":608.58,"total_display":"608.58","total_whole":"609","shares_owned_after":720639.0,"shares_owned_after_display":"720,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-17","scope":"insider"},{"id":7831908,"accession":"0001181431-07-054816","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-07-054816","line_url":"/filing/0001181431-07-054816#line-1","is_derivative":false,"issuer_cik":"0001319197","issuer_name":"Coley Pharmaceutical Group, Inc.","issuer_ticker":"COLY","issuer_name_source":null,"issuer_url":"/issuer/0001319197","owner_cik":"0001335659","owner_name":"Krieg Arthur M","owner_display_name":"Krieg Arthur M","owner_url":"/insider/0001335659","role":"Officer (SVP, R & D, Chief Scien. Off)","role_mark":"O","role_mark_label":"Officer (SVP, R & D, Chief Scien. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, R & D, Chief Scien. Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21070.0,"shares_display":"21,070","price_per_share":1.89,"price_display":"1.89","price_state":"stated","total_value":39822.3,"total_display":"39,822.30","total_whole":"39,822","shares_owned_after":545602.0,"shares_owned_after_display":"545,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-29","filed_date":"2007-08-29","scope":"insider"},{"id":4706666,"accession":"0001181431-06-068713","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-06-068713","line_url":"/filing/0001181431-06-068713#line-2","is_derivative":false,"issuer_cik":"0001319197","issuer_name":"Coley Pharmaceutical Group, Inc.","issuer_ticker":"COLY","issuer_name_source":null,"issuer_url":"/issuer/0001319197","owner_cik":"0001335659","owner_name":"Krieg Arthur M","owner_display_name":"Krieg Arthur M","owner_url":"/insider/0001335659","role":"Officer (SVP, R & D, Chief Scien. Off)","role_mark":"O","role_mark_label":"Officer (SVP, R & D, Chief Scien. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, R & D, Chief Scien. Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18122.0,"shares_display":"18,122","price_per_share":2.24,"price_display":"2.24","price_state":"stated","total_value":40593.28,"total_display":"40,593.28","total_whole":"40,593","shares_owned_after":566972.0,"shares_owned_after_display":"566,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-12-07","filed_date":"2006-12-11","scope":"insider"},{"id":3894372,"accession":"0001181431-06-058181","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-06-058181","line_url":"/filing/0001181431-06-058181#line-1","is_derivative":false,"issuer_cik":"0001319197","issuer_name":"Coley Pharmaceutical Group, Inc.","issuer_ticker":"COLY","issuer_name_source":null,"issuer_url":"/issuer/0001319197","owner_cik":"0001335659","owner_name":"Krieg Arthur M","owner_display_name":"Krieg Arthur M","owner_url":"/insider/0001335659","role":"Officer (SVP, R & D, Chief Scien. Off)","role_mark":"O","role_mark_label":"Officer (SVP, R & D, Chief Scien. Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, R & D, Chief Scien. Off.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13210.0,"shares_display":"13,210","price_per_share":1.89,"price_display":"1.89","price_state":"stated","total_value":24966.9,"total_display":"24,966.90","total_whole":"24,967","shares_owned_after":585094.0,"shares_owned_after_display":"585,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-10-13","filed_date":"2006-10-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001651431","name":"Checkmate Pharmaceuticals, Inc.","url":"/issuer/0001651431","role":"Officer (Chief Scientific Officer)","n_filings":10,"first_seen":"2020-12-17","last_seen":"2021-06-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001319197","name":"Coley Pharmaceutical Group, Inc.","url":"/issuer/0001319197","role":"Officer (SVP, R & D, Chief Scien. Off)","n_filings":3,"first_seen":"2006-10-16","last_seen":"2007-08-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001335659","retrieved_at":"2026-08-26T20:08:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}